Chris Howerton Downgraded (VNDA) to Hold and Decreased Target to $12 on, Feb 25th, 2022


Published on 2024-10-27 19:51:35 - WOPRAI, Chris Howerton
  Print publication without navigation


Chris Howerton of Jefferies, Downgraded "Vanda Pharmaceuticals Inc." (VNDA) to Hold and Decreased Target from $24 to $12 on, Feb 25th, 2022.

Chris, nor any peers, have made any analyst calls on VNDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources